cystic fibrosis cf clinical condition patients correlates poorly genotype possible explanation clinical status influenced net preserved chloride secretion cf mutation tested relationships residual chloride secretion measured nasal potential difference pd type mutation genotypes expressing apical cystic fibrosis transmembrane conductance regulator cftr protein versus clinical status cf patients mean age NUMBER yrs NUMBER females NUMBER males mean forced expiratory volume second fev1 NUMBER predicted defined genotypes recruited nasal pd measured using standard protocol involving perfusion nasal epithelium sodium channel blocker amiloride followed solution low chloride finally isoprenaline patients apical cftr protein showed higher residual chloride secretion amiloride isoprenaline value NUMBER NUMBER mv respectively p NUMBER correlation mutation type clinical condition patients recategorized high NUMBER mv amiloride isoprenaline response low NUMBER mv chloride secretors group significantly higher fev1 NUMBER versus NUMBER pred better pulmonary radiological score NUMBER versus NUMBER northern scoring results suggest cystic fibrosis patients regardless genotype ability secrete chloride stimulated chloride secretatagogues correlated better lung function results implications use potential difference measurements novel cystic fibrosis transmembrane conductance regulator replacement trials